Interstitial Lung Disease Trial, Recruiting (NCT03437486)

Interstitial Lung Disease Trial, Recruiting NCT03437486 Sponsor: Vanderbilt University Medical Center Condition: Interstitial Lung Disease

Printed from Voxsanity (voxsanity.com.au) — NCT03437486 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Interstitial Lung Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are a blood relative of someone diagnosed with Idiopathic Interstitial Pneumonia (IIP), where at least two members of the same family have been diagnosed with IIP
People who have not themselves been diagnosed with IIP or IPF (a type of lung scarring condition)
People who are a brother, sister, or adult child of someone with IIP

Who may not be able to join:

People who are unable to understand what the study involves, or who are unwilling to sign a written consent form
People who are unable to travel to Nashville for 1 to 2 outpatient visits, or who are unable to complete a questionnaire about interstitial lung disease (either on paper or online)
People younger than 40 or older than 75 years of age — though if the affected family member was diagnosed with IIP before age 50, people aged 18 to 40 may be considered if they are within 10 years younger than the age their relative was at diagnosis (confirm with trial site)
People who have another condition that may cause similar symptoms to IIP or IPF, such as rheumatoid arthritis, other connective tissue diseases, lung disease caused by workplace exposures, or previous chemotherapy
People the trial investigators consider unsuitable for participation for any other reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03437486

Sponsor: Vanderbilt University Medical Center

Phase: Not Applicable

Status: Recruiting

Condition: Interstitial Lung Disease

More information: https://clinicaltrials.gov/study/NCT03437486

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are a blood relative of someone diagnosed with Idiopathic Interstitial Pneumonia (IIP), where at least two members of the same family have been diagnosed with IIP
People who have not themselves been diagnosed with IIP or IPF (a type of lung scarring condition)
People who are a brother, sister, or adult child of someone with IIP

Who may not be able to join:

People who are unable to understand what the study involves, or who are unwilling to sign a written consent form
People who are unable to travel to Nashville for 1 to 2 outpatient visits, or who are unable to complete a questionnaire about interstitial lung disease (either on paper or online)
People younger than 40 or older than 75 years of age — though if the affected family member was diagnosed with IIP before age 50, people aged 18 to 40 may be considered if they are within 10 years younger than the age their relative was at diagnosis (confirm with trial site)
People who have another condition that may cause similar symptoms to IIP or IPF, such as rheumatoid arthritis, other connective tissue diseases, lung disease caused by workplace exposures, or previous chemotherapy
People the trial investigators consider unsuitable for participation for any other reason

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Vanderbilt University Medical Center

Registry

ClinicalTrials.gov

Start date

1 January 2009

Est. completion

30 January 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

clinical diagnosis of interstitial lung disease

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov